Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
This article helps you determine Which Aristocrats ETF Has The Lowest Fees by comparing expense ratios and related costs across top funds.
27,507 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
XRP is testing a rare monthly RSI low that historians say has preceded big rallies before. Traders weigh the odds as ...
Microsoft faces a landmark decision as its OpenAI stake fuels an expanding AI push. The company must balance monetizi...
As Coca-Cola climbs toward milestone prices, investors ask if could coca-cola issue stock in a split. This guide brea...
Regulators signal a softer approach while a Trump-linked venture secures $75 million from Justin Sun, fueling specula...
In Florida, trump hates voting mail—except, as ballots are cast, the president shows a paradox that highlights the po...
Hims & Hers is set to report Q1 earnings after the close as investors weigh a rebound in shares and the pace of cash ...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...
When tech stocks wobble, patient investors can uncover glorious growth stocks during downturns. This piece highlights...
Marvell Technology surged to new heights as whispers about AWS opening Trainium to external buyers drew investor atte...
Intel's turnaround gains traction amid AI-driven demand and a narrowing foundry loss gap, fueling a debate about whet...
Netflix walks away from an $83 billion Warner Bros. deal, freeing capital for expansion and content, lifting the stoc...